PI
MNTA

PineBridge Investments’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

PineBridge Investments’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-54,169
Closed -$1.07M – 1102
2019
Q4 		$1.07M Sell
54,169
-45,488
-46% -$727K 0.02% 553
2019
Q3 		$1.29M Buy
99,657
+1,962
+2% +$23.7K 0.02% 624
2019
Q2 		$1.22M Buy
97,695
+25,179
+35% +$334K 0.02% 585
2019
Q1 		$1.05M Buy
72,516
+51,841
+251% +$662K 0.02% 530
2018
Q4 		$228K Buy
20,675
+4,338
+27% +$60.4K 0.01% 837
2018
Q3 		$430K Buy
16,337
+1,860
+13% +$50.3K 0.01% 778
2018
Q2 		$296K Sell
14,477
-2,704
-16% -$58K 0.01% 796
2018
Q1 		$311K Sell
17,181
-25,535
-60% -$426K 0.01% 790
2017
Q4 		$596K Buy
42,716
+33,257
+352% +$450K 0.02% 760
2017
Q3 		$175K Buy
9,459
+661
+8% +$11.1K ﹤0.01% 855
2017
Q2 		$149K Buy
8,798
+363
+4% +$5.53K ﹤0.01% 855
2017
Q1 		$113K Buy
8,435
+143
+2% +$2.24K ﹤0.01% 905
2016
Q4 		$125K Buy
8,292
+339
+4% +$4.48K ﹤0.01% 939
2016
Q3 		$93K Sell
7,953
-67
-0.8% -$788 ﹤0.01% 811
2016
Q2 		$87K Buy
8,020
+654
+9% +$6.75K ﹤0.01% 820
2016
Q1 		$68K Sell
7,366
-1,047
-12% -$11.3K ﹤0.01% 840
2015
Q4 		$125K Buy
8,413
+852
+11% +$14.3K 0.01% 693
2015
Q3 		$124K Buy
7,561
+713
+10% +$14.6K 0.01% 685
2015
Q2 		$156K Sell
6,848
-5,195
-43% -$103K 0.01% 589
2015
Q1 		$183K Buy
12,043
+1,127
+10% +$14.6K 0.01% 760
2014
Q4 		$132K Buy
10,916
+1,050
+11% +$12K 0.01% 851
2014
Q3 		$111K Buy
9,866
+2,742
+38% +$31.3K ﹤0.01% 832
2014
Q2 		$86K Sell
7,124
-4,392
-38% -$51.9K ﹤0.01% 838
2014
Q1 		$134K Sell
11,516
-1,068
-8% -$18.1K ﹤0.01% 884
2013
Q4 		$222K Buy
12,584
+7,496
+147% +$126K 0.01% 748
2013
Q3 		$73K Hold
5,088
– – ﹤0.01% 829
2013
Q2 		$77K Buy
+5,088
New +$67.1K ﹤0.01% 798

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

PineBridge Investments's MNTA Position: Q1 2020 in Review

PineBridge Investments sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2020, closing a stake of 54,169 shares — an estimated $1.07M sold.

PineBridge Investments first reported a position in MNTA in Q2 2013 and held it in 27 quarters. The position peaked at $1.29M in Q3 2019. 199 funds tracked by Wall St. Rank hold MNTA as of Q1 2020.

  • PineBridge Investments reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • PineBridge Investments sold 54,169 Momenta Pharmaceuticals, Inc. shares in Q1 2020, an estimated $1.07M.
  • PineBridge Investments first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 27 quarters.
  • PineBridge Investments's Momenta Pharmaceuticals, Inc. position peaked at $1.29M in Q3 2019.
  • 199 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2020.

Based on PineBridge Investments's 13F filing for Q1 2020, filed 14 May 2020.